Cooper Companies Inc (COO) Position Boosted by Stifel Financial Corp

Stifel Financial Corp boosted its holdings in shares of Cooper Companies Inc (NYSE:COO) by 10.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,065 shares of the medical device company’s stock after acquiring an additional 1,181 shares during the quarter. Stifel Financial Corp’s holdings in Cooper Companies were worth $2,857,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in shares of Cooper Companies by 3.3% in the 2nd quarter. Vanguard Group Inc. now owns 4,938,181 shares of the medical device company’s stock worth $1,182,298,000 after buying an additional 156,449 shares during the period. BlackRock Inc. lifted its holdings in shares of Cooper Companies by 4.5% in the 2nd quarter. BlackRock Inc. now owns 3,210,032 shares of the medical device company’s stock worth $768,546,000 after buying an additional 138,395 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Cooper Companies by 558.5% in the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock worth $520,937,000 after buying an additional 1,845,368 shares during the period. Amundi Pioneer Asset Management Inc. lifted its holdings in shares of Cooper Companies by 2.2% in the 3rd quarter. Amundi Pioneer Asset Management Inc. now owns 1,252,938 shares of the medical device company’s stock worth $297,084,000 after buying an additional 26,688 shares during the period. Finally, Westfield Capital Management Co. LP lifted its holdings in shares of Cooper Companies by 47.8% in the 3rd quarter. Westfield Capital Management Co. LP now owns 636,882 shares of the medical device company’s stock worth $151,011,000 after buying an additional 206,003 shares during the period. Institutional investors own 96.73% of the company’s stock.

In other news, Director Gary S. Petersmeyer sold 785 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $229.06, for a total value of $179,812.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.

COO has been the subject of several research reports. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday, September 18th. KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a report on Monday, August 28th. Robert W. Baird reiterated a “buy” rating and issued a $267.00 target price (up from $251.00) on shares of Cooper Companies in a report on Sunday, September 3rd. Raymond James Financial reiterated a “buy” rating and issued a $265.00 target price on shares of Cooper Companies in a report on Monday, December 4th. Finally, BMO Capital Markets reissued a “buy” rating and issued a $272.00 price target on shares of Cooper Companies in a research report on Friday, October 13th. Six investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $259.70.

Cooper Companies Inc (COO) opened at $223.88 on Wednesday. The company has a market capitalization of $10,967.57, a price-to-earnings ratio of 23.05, a PEG ratio of 1.81 and a beta of 0.54. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.41 and a quick ratio of 1.26. Cooper Companies Inc has a 1 year low of $172.83 and a 1 year high of $256.39.

Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.64 by $0.01. The firm had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.28 EPS. research analysts anticipate that Cooper Companies Inc will post 11.51 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://sportsperspectives.com/2017/12/20/cooper-companies-inc-coo-position-boosted-by-stifel-financial-corp.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply